BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23564467)

  • 41. African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population.
    Cavalcante LN; Porto J; Mazo D; Longatto-Filho A; Stefano JT; Lyra AC; Carrilho FJ; Reis RM; Alves VAF; Sanyal AJ; Oliveira CP
    Ann Hepatol; 2022; 27(6):100728. PubMed ID: 35710086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.
    Kozlitina J; Boerwinkle E; Cohen JC; Hobbs HH
    Hepatology; 2011 Feb; 53(2):467-74. PubMed ID: 21274868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China.
    Li Y; Xing C; Cohen JC; Hobbs HH
    Hepatology; 2012 Jan; 55(1):327-8. PubMed ID: 21898508
    [No Abstract]   [Full Text] [Related]  

  • 44. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
    Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
    Petta S; Valenti L; Marchesini G; Di Marco V; Licata A; Cammà C; Barcellona MR; Cabibi D; Donati B; Fracanzani A; Grimaudo S; Parrinello G; Pipitone RM; Torres D; Fargion S; Licata G; Craxì A
    PLoS One; 2013; 8(9):e74089. PubMed ID: 24069270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients.
    Huang CF; Chen JJ; Yeh ML; Huang CI; Hsieh MY; Yang HL; Dai CY; Huang JF; Lin ZY; Chen SC; Chuang WL; Chen YL; Yu ML
    Sci Rep; 2015 Jul; 5():11901. PubMed ID: 26139292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
    Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ;
    Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort.
    Wing MR; Ziegler JM; Langefeld CD; Roh BH; Palmer ND; Mayer-Davis EJ; Rewers MJ; Haffner SM; Wagenknecht LE; Bowden DW
    Int J Obes (Lond); 2011 Sep; 35(9):1173-82. PubMed ID: 21102551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.
    Petta S; Miele L; Bugianesi E; Cammà C; Rosso C; Boccia S; Cabibi D; Di Marco V; Grimaudo S; Grieco A; Pipitone RM; Marchesini G; Craxì A
    PLoS One; 2014; 9(2):e87523. PubMed ID: 24498332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
    Trépo E; Pradat P; Potthoff A; Momozawa Y; Quertinmont E; Gustot T; Lemmers A; Berthillon P; Amininejad L; Chevallier M; Schlué J; Kreipe H; Devière J; Manns M; Trépo C; Sninsky J; Wedemeyer H; Franchimont D; Moreno C
    Hepatology; 2011 Jul; 54(1):60-9. PubMed ID: 21488075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transethnic Evaluation Identifies Low-Frequency Loci Associated With 25-Hydroxyvitamin D Concentrations.
    Hong J; Hatchell KE; Bradfield JP; Bjonnes A; Chesi A; Lai CQ; Langefeld CD; Lu L; Lu Y; Lutsey PL; Musani SK; Nalls MA; Robinson-Cohen C; Roizen JD; Saxena R; Tucker KL; Ziegler JT; Arking DE; Bis JC; Boerwinkle E; Bottinger EP; Bowden DW; Gilsanz V; Houston DK; Kalkwarf HJ; Kelly A; Lappe JM; Liu Y; Michos ED; Oberfield SE; Palmer ND; Rotter JI; Sapkota B; Shepherd JA; Wilson JG; Basu S; de Boer IH; Divers J; Freedman BI; Grant SFA; Hakanarson H; Harris TB; Kestenbaum BR; Kritchevsky SB; Loos RJF; Norris JM; Norwood AF; Ordovas JM; Pankow JS; Psaty BM; Sanghera DK; Wagenknecht LE; Zemel BS; Meigs J; Dupuis J; Florez JC; Wang T; Liu CT; Engelman CD; Billings LK
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1380-1392. PubMed ID: 29325163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.
    Santoro N; Kursawe R; D'Adamo E; Dykas DJ; Zhang CK; Bale AE; Calí AM; Narayan D; Shaw MM; Pierpont B; Savoye M; Lartaud D; Eldrich S; Cushman SW; Zhao H; Shulman GI; Caprio S
    Hepatology; 2010 Oct; 52(4):1281-90. PubMed ID: 20803499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Polymorphisms in adiponutrin gene and association to hepatic steatosis].
    Baulande S
    Med Sci (Paris); 2009 Feb; 25(2):130-2. PubMed ID: 19239840
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.
    Larrieta-Carrasco E; Flores YN; Macías-Kauffer LR; Ramírez-Palacios P; Quiterio M; Ramírez-Salazar EG; León-Mimila P; Rivera-Paredez B; Cabrera-Álvarez G; Canizales-Quinteros S; Zhang ZF; López-Pérez TV; Salmerón J; Velázquez-Cruz R
    Exp Mol Pathol; 2018 Feb; 104(1):50-58. PubMed ID: 29307798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Four-Week Omega-3 Supplementation in Carriers of the Prosteatotic PNPLA3 p.I148M Genetic Variant: An Open-Label Study.
    Kuttner CS; Mancina R; Wagenpfeil G; Lammert F; Stokes CS
    Lifestyle Genom; 2019; 12(1-6):10-17. PubMed ID: 31454802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
    Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
    J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci.
    Stender S; Kozlitina J; Nordestgaard BG; Tybjærg-Hansen A; Hobbs HH; Cohen JC
    Nat Genet; 2017 Jun; 49(6):842-847. PubMed ID: 28436986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry.
    Liu C; Zeinomar N; Chung WK; Kiryluk K; Gharavi AG; Hripcsak G; Crew KD; Shang N; Khan A; Fasel D; Manolio TA; Jarvik GP; Rowley R; Justice AE; Rahm AK; Fullerton SM; Smoller JW; Larson EB; Crane PK; Dikilitas O; Wiesner GL; Bick AG; Terry MB; Weng C
    JAMA Netw Open; 2021 Aug; 4(8):e2119084. PubMed ID: 34347061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals.
    Chalazan B; Mol D; Darbar FA; Ornelas-Loredo A; Al-Azzam B; Chen Y; Tofovic D; Sridhar A; Alzahrani Z; Ellinor P; Darbar D
    JAMA Cardiol; 2021 Jul; 6(7):811-819. PubMed ID: 33950154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients.
    Liu ZT; Chen TC; Lu XX; Cheng J; Xie HY; Zhou L; Zheng SS
    World J Gastroenterol; 2015 Sep; 21(34):10054-6. PubMed ID: 26379412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.